A chemical compound that has had one or more of its atoms replaced by a radionuclide is known as a Radioactive Tracer, radiotracer, or radioactive label. Because of its radioactive decay, radioactive tracer compounds can be used to investigate the mechanism of chemical reactions by tracing the path that the radioisotope takes from reactants to products. Thus, the radioactive version of isotopic labelling is radiolabelling or radiotracing. The use of radioactive tracers is commonly referred to as radioisotope feeding experiments in biological contexts. It has been extensively used to follow the course of biological reactions to employ radioisotopes of hydrogen, carbon, phosphorus, sulfur, and iodine. A radioactive tracer can also be employed as a flow tracer or to monitor a substance's distribution inside a natural system like a cell or tissue. In the process of producing natural gas, radioactive tracers are also utilised to locate cracks caused by hydraulic fracturing. A number of imaging methods, including technetium scans, SPECT scans, and PET scans, are based on radioactive tracers. Carbon-14, an isotope that occurs naturally, is used in radiocarbon dating as an isotopic label.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia